People taking certain antidepressants are at higher risk of developing dementia, reveals study

In a new study, it has been revealed that people taking more antidepressants are at higher risk of developing dementia. That means if you are used to taking commonly prescribed antidepressants then there is a high chance that you may suffer from dementia.

The scientists have also revealed that dementia due to intake of antidepressants, may even occur 20 years before the actual diagnosis. Dementia is the gradual decline in the mental ability severe enough to reduce a person’s ability to perform everyday activities. So dementia is particularly a broad category of brain diseases that occur when the brain cells get damaged.

Nowadays, more and more people are showing symptoms of dementia and scientists are trying their best to know what causes dementia and how the disease can be treated effectively. And, as per the latest reports, a group of scientists from the US, UK, and Ireland has found of from their extensive study that taking more antidepressants may increase the risk of developing dementia in people.

The scientists found out that the patients who are prescribed anticholinergic antidepressants, anticholinergic Parkinson’s disease medications and anticholinergic bladder medications showed a higher chance of developing dementia than those who were not prescribed such antidepressant drugs. Noll Campbell, assistant professor at the Purdue University in Indiana said, “Anticholinergics, medications that block acetylcholine, a nervous system neurotransmitter, have previously been implicated as a potential cause of cognitive impairment.”

But according to the researchers, they could not crack down exactly how anticholinergics might cause dementia. For the research, the scientists scrutinized more than 27 million prescriptions collected from the medical records of a total of 40,770 patients aged over 65 and diagnosed with dementia and over 283,933 older adults not suffering from dementia. The scientists then compared the medical records of the patients diagnosed with dementia to the older adults without dementia.

Malaz Boustani, from the US-based Regenstrief Institute, informed that the latest findings have made it clear that the clinicians need to carefully consider the anticholinergic burden of their patients and weigh other options. Boustani said that the physicians should consider reviewing all the anticholinergic medications, including over-the-counter drugs that patients of all ages consume and figure out the safe ways to take individuals off anticholinergic medications in the interest of preserving brain health.

About the author

Saloni Sharma

Saloni Sharma is an environmental activist with broad, deep experience in print and online writing, publication and site management, news coverage, and editorial team management.

Add Comment

Click here to post a comment

You Might Also Like